These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32802215)

  • 1. Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy (with or without Chemotherapy) in Patients with Stage IB2, IIA, or IIB Cervical Cancer: A Systematic Review and Meta-Analysis.
    Ye Q; Yang Y; Tang X; Li J; Li X; Zhang Y
    Dis Markers; 2020; 2020():7415056. PubMed ID: 32802215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Olaitan A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD010260. PubMed ID: 35994243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stage IB2-IIB cervical cancer: A systematic review and meta-analysis.
    Zou W; Han Y; Zhang Y; Hu C; Feng Y; Zhang H; Wang J
    PLoS One; 2019; 14(11):e0225264. PubMed ID: 31725793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis.
    Cheng J; Liu B; Wang B; Long X; Li Z; Chen R; Wu R; Xu L
    BMC Cancer; 2021 Oct; 21(1):1078. PubMed ID: 34615494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concurrent Chemo-Radiotherapy in the Treatment of Locally Advanced Cervical Cancer: A Multicenter Retrospective Analysis.
    Sala P; Bogliolo S; Barra F; Fazio A; Maramai M; Cassani C; Gardella B; Babilonti L; Giannelli F; Mammoliti S; Spinillo A; Ferrero S; Valenzano Menada M; Costantini S; Bruzzi P; Marchiolè P
    J Invest Surg; 2022 Feb; 35(2):308-314. PubMed ID: 33289585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.
    Zeng J; Sun P; Ping Q; Jiang S; Hu Y
    PLoS One; 2022; 17(3):e0266001. PubMed ID: 35324998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994.
    Kenter GG; Greggi S; Vergote I; Katsaros D; Kobierski J; van Doorn H; Landoni F; van der Velden J; Reed N; Coens C; van Luijk I; Colombo N; Steen-Banasik EV; Ottevanger N; Casado A;
    J Clin Oncol; 2023 Nov; 41(32):5035-5043. PubMed ID: 37656948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
    Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stages IB2 to IIB of cervical cancer: a meta-analysis.
    Gao Y; Wang H; Jiang M
    Front Oncol; 2024; 14():1426002. PubMed ID: 38978730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the survival outcome of neoadjuvant therapy followed by radical surgery with that of concomitant chemoradiotherapy in patients with stage IB2-IIIB cervical adenocarcinoma.
    Tian T; Gao X; Ju Y; Ding X; Ai Y
    Arch Gynecol Obstet; 2021 Mar; 303(3):793-801. PubMed ID: 33009996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB-IVA cervical cancer: study protocol for a randomized controlled trial.
    Li J; Liu H; Li Y; Li J; Shen L; Long W; Yang C; Xu H; Xi W; Cai R; Feng W
    Trials; 2022 Jan; 23(1):29. PubMed ID: 35012634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study.
    Ouyang P; Cai J; Gui L; Liu S; Wu NY; Wang J
    Arch Gynecol Obstet; 2020 May; 301(5):1247-1255. PubMed ID: 32221709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy followed by surgery versus concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma: a retrospective cohort study.
    Pan XB; Lu Y; Wei YS; Yao DS
    BMC Cancer; 2024 May; 24(1):655. PubMed ID: 38811880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study.
    Benedetti-Panici P; Greggi S; Colombo A; Amoroso M; Smaniotto D; Giannarelli D; Amunni G; Raspagliesi F; Zola P; Mangioni C; Landoni F
    J Clin Oncol; 2002 Jan; 20(1):179-88. PubMed ID: 11773168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study.
    Kondo E; Yoshida K; Tabata T; Kobayashi Y; Yamagami W; Ebina Y; Kaneuchi M; Nagase S; Machida H; Mikami M
    J Gynecol Oncol; 2022 Mar; 33(2):e14. PubMed ID: 34910395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.
    Lin Q; Lu L; Wang X; Lin Y; Chen Y; Chen H; Chen S; Lin S; Zhang Y; Zheng P; Chen X
    Am J Otolaryngol; 2022; 43(1):103193. PubMed ID: 34509080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor.
    Li F; Mei F; Yin S; Du Y; Hu L; Hong W; Li J
    J Gynecol Oncol; 2024 Jan; 35(1):e10. PubMed ID: 37857565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
    BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.